Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Database
Journal subject
Affiliation country
Publication year range
1.
Neuroscience ; 156(4): 973-86, 2008 Oct 28.
Article in English | MEDLINE | ID: mdl-18809471

ABSTRACT

The contribution of (R)-enantiomer of N-methyl-salsolinol (1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline; NMSal) to the degeneration of dopaminergic neurons in the course of Parkinson's disease (PD) has been predominantly suggested by in vitro experiments in cell culture and by an in vivo study in which this compound has been directly injected into the rat striatum. The aim of the present study was to examine the effects of racemic NMSal (50 and 100 mg/kg) administered systemically, acutely and chronically for 21 days to rats, on the neurochemical and behavioral markers of PD. Our results showed that racemic NMSal easily penetrated the blood-brain barrier. Its brain level was relatively high 2-6 h after a single injection than gradually decreased. NMSal was quickly eliminated from the rat brain, its concentration 24 h after withdrawal from chronic treatment was very low. NMSal at both examined doses did not affect striatal and nigral levels of dopamine (DA) 2 h after the first and last chronic injections, however, it markedly changed DA catabolism. In the striatum both its doses evoked a significant acceleration of the total and oxidative, monoamine oxidase (MAO)-dependent DA catabolism without affecting the catechol-O-methyltransferase (COMT)-dependent O-methylation. In the substantia nigra (SN), only the higher dose of NMSal produced such effect. DA catabolism in either structure was the same as in control 24 h after cessation of chronic treatment. The second characteristic marker of PD, the number of tyrosine hydroxylase-immunoreactive (TH-ir) neurons in the SN, was not affected by chronic NMSal treatment as revealed by the stereological counting. In the behavioral study, it was found that racemic NMSal significantly suppressed spontaneous locomotor activity and effectively prevented that stimulated by apomorphine. Our results suggest that NMSal may play an important role in the regulation of dopaminergic activity rather than in inducing changes of parkinsonian type.


Subject(s)
Corpus Striatum/drug effects , Dopamine/metabolism , Substantia Nigra/drug effects , Tetrahydroisoquinolines/administration & dosage , Amphetamine/pharmacology , Animals , Behavior, Animal/drug effects , Brain Chemistry/drug effects , Corpus Striatum/cytology , Corpus Striatum/physiology , Dopamine Uptake Inhibitors/pharmacology , Drug Administration Schedule , Drug Interactions , Electromyography , Male , Mitochondria, Muscle/drug effects , Mitochondria, Muscle/ultrastructure , Motor Activity/drug effects , Muscle, Skeletal/drug effects , Muscle, Skeletal/physiology , Muscle, Skeletal/ultrastructure , Neural Pathways/drug effects , Neural Pathways/physiology , Neurons/drug effects , Neurons/metabolism , Rats , Rats, Wistar , Substance Withdrawal Syndrome/physiopathology , Substantia Nigra/physiology , Tetrahydroisoquinolines/metabolism , Time Factors , Tissue Distribution , Tyrosine 3-Monooxygenase/metabolism
2.
Neuroscience ; 141(4): 2155-65, 2006 Sep 15.
Article in English | MEDLINE | ID: mdl-16797138

ABSTRACT

A deficiency of the dopaminergic transmission in the mesocortical system has been suggested to contribute to cognitive disturbances in Parkinson's disease. Therefore, the aim of the present study was to examine whether the long-term administration of a commonly used herbicide, paraquat, which has already been found to induce a slowly progressing degeneration of the nigrostriatal neurons, influences mesocortical dopaminergic neurons in rats. Paraquat at a dose of 10 mg/kg i.p. was injected either acutely or once a week for 4, 8, 12 and 24 weeks. Acute treatment with this pesticide increased the level of homovanillic acid (HVA) and HVA/dopamine ratio in the prefrontal cortex. After 8 weeks of administration paraquat increased the number of stereologically counted tyrosine hydroxylase-immunoreactive (TH-ir) neurons and their staining intensity in the ventral tegmental area (VTA), which is a source of the mesocortical dopaminergic projection. At the same time, few TH-ir neurons appeared in different regions of the cerebral cortex: in the frontal, cingulate, retrosplenial and parietal cortices. Chronic paraquat administration did not influence the level of dopamine in the prefrontal cortex but increased the levels of its metabolites: 3,4-dihydroxyphenylacetic acid (after 8-12 weeks), HVA (after 4 and 12 weeks) and HVA/dopamine ratio (4 weeks). After 24 weeks this pesticide reduced the number of TH-ir neurons in the VTA by 42% and of the Nissl-stained neurons by 26%, and induced shrinkage of this structure by ca. 25%. Moreover, TH-ir neurons in the cortex were no more visible after such a long period of administration and levels of dopamine metabolites returned to control values. The present results suggest that the long-term paraquat administration destroys dopaminergic neurons of the VTA. However, compensatory activation of the VTA neurons and cortex overcomes progressing degeneration and maintains cortical dopaminergic transmission.


Subject(s)
Cerebral Cortex/cytology , Dopamine/metabolism , Herbicides/administration & dosage , Nerve Degeneration/chemically induced , Neurons/drug effects , Paraquat/administration & dosage , 3,4-Dihydroxyphenylacetic Acid/metabolism , Animals , Behavior, Animal/drug effects , Chromatography, High Pressure Liquid/methods , Disease Models, Animal , Homovanillic Acid/metabolism , Immunohistochemistry/methods , Male , Nerve Degeneration/metabolism , Nerve Degeneration/pathology , Nerve Degeneration/physiopathology , Parkinsonian Disorders/chemically induced , Parkinsonian Disorders/pathology , Parkinsonian Disorders/physiopathology , Rats , Rats, Wistar , Tyrosine 3-Monooxygenase/metabolism , Ventral Tegmental Area/metabolism , Ventral Tegmental Area/pathology
5.
Eur J Neurosci ; 22(6): 1294-304, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16190885

ABSTRACT

The aim of the present study was to examine the influence of the long-term paraquat administration on the dopaminergic nigrostriatal system in rats. Paraquat was injected at a dose of 10 mg/kg i.p. for 4-24 weeks. We found that this pesticide reduced the number of tyrosine hydroxylase-immunoreactive neurons of the substantia nigra; after the 4-week treatment the reduction (17%, nonsignificant) was confined to the rostrocentral region of this structure but, after 24 weeks, had spread along its whole length and was approximately 37%. Moreover, it induced a biphasic effect on dopaminergic transmission. First, levels of dopamine, its metabolites and turnover were elevated (4-8 weeks) in the caudate-putamen, then all these parameters returned to control values (12 weeks) and dropped by 25-30% after 24 weeks. The binding of [3H]GBR 12,935 to dopamine transporter in the caudate-putamen was decreased after 4-8 weeks, then returned to control values after 12 weeks but was again decreased after 24 weeks. Twenty-four-week paraquat administration also decreased the level of tyrosine hydroxylase (Western blot) in the caudate-putamen. In addition, paraquat activated serotonin and noradrenaline transmission during the first 12 weeks of treatment but no decreases in levels of these neurotransmitters were observed after 24 weeks. The above results seem to suggest that long-term paraquat administration produces a slowly progressing degeneration of nigrostriatal neurons, leading to delayed deficits in dopaminergic transmission, which may resemble early, presymptomatic, stages of Parkinson's disease.


Subject(s)
Dopamine/physiology , Herbicides/toxicity , Neurons/pathology , Paraquat/toxicity , Parkinson Disease, Secondary/chemically induced , Parkinson Disease, Secondary/pathology , Substantia Nigra/cytology , Algorithms , Animals , Autoradiography , Caudate Nucleus/metabolism , Dopamine/metabolism , Male , Neurons/drug effects , Neurons/metabolism , Neurotransmitter Agents/metabolism , Norepinephrine/metabolism , Parkinson Disease, Secondary/metabolism , Piperazines/pharmacology , Putamen/metabolism , Rats , Rats, Wistar , Serotonin/metabolism , Substantia Nigra/drug effects , Substantia Nigra/metabolism , Synaptic Transmission/drug effects , Tyrosine 3-Monooxygenase/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL